Aminocaproic Acid

This page contains recent news articles, when available, and an overview of Aminocaproic Acid but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Aminocaproic acid swab rumours are unfounded  -  ‎Nov 10, 2009‎
HARNESS racing has been abuzz with rumours that more Tasmanian horses have returned positive swabs to aminocaproic acid, but they are ... Tasmania Examiner

Racing: Appeal adjourned  -  ‎Nov 6, 2009‎
He is also contesting a charge in Victoria after his horse, Zenad, returned a positive test to the anti-bleeding drug aminocaproic acid. ... New Zealand Herald

Key Words: Aprotinin • Cardiac surgery • Mortality • Late survival  -  ‎Oct 27, 2009‎
Another intriguing finding was found, namely that the risk of late cardiac death was higher in patients who received aprotinin than after aminocaproic acid ... European Journal of Cardio-Thoracic Surgery (subscription)

Racing crackdown on new blood drug  -  30 Aug 2009
Aminocaproic acid is a therapeutic drug which is being used in racehorses to prevent internal bleeding, thus improving performance. Daily Telegraph

Harness Racing  -  ‎Aug 29, 2009‎
Beattie also issued a warning to industry participants about aminocaproic acid, which is a prohibited substance. ''The suppliers have been dispensing Sydney Morning Herald

Rawiller, Shinn hang tough to chase Rose  -  ‎Aug 28, 2009‎
Meanwhile, he issued a further warning to trainers to be aware of the presence of the prohibited substance aminocaproic acid. ''It is anticipated there is Sydney Morning Herald

Rosehill EPO samples negative  -  ‎Aug 27, 2009‎
...dispensed and labelled in accordance with state legislation, with particular emphasis being placed on the prohibited substance aminocaproic acid. Bloodstock.com.au

ThoroughbredNEWS News Desk  -  ‎Aug 16, 2009‎
Racing NSW chief steward Ray Murrihy on Monday issued a warning to trainer and others in the racing industry that they are warned that aminocaproic acid is ThoroughbredNews.co.nz

First positive to banned drug  -  ‎Aug 19, 2009‎
THE first of what may be a number of positive tests to the banned substance aminocaproic acid has been returned in thoroughbred racing. Sydney Morning Herald

Official calls for US to ban Lasix in stakes  -  ‎Aug 23, 2009‎
In addition, Gorajec called on regulators to immediately ban the use of so-called adjunct bleeder medications-- such as aminocaproic acid and conjugated Daily Racing Form (registration)

Sink or swim: trainer trusting his judgment as colt takes on big guns  -  ‎Aug 18, 2009‎
The alarm was sounded on Monday, with stewards declaring aminocaproic acid (ACA) has no place in the thoroughbred racing industry. Brisbane Times

Bleeding Disorders May Cause Menorrhagia and Postpartum Hemorrhage  -  ‎Jun 22, 2009‎
Tranexamic acid and aminocaproic acid or desmopressin (DDAVP) is useful for the treatment of menorrhagia in combined factor V or factor VIII deficiency, Medscape

Impact of preoperative clopidogrel in off pump coronary artery ...  -  Jan 30, 2009
It has been customary in our institution to refrain from administering hemostatic drugs such as aprotinin or aminocaproic acid. The Journal of Thoracic and Cardiovascular Surgery

Another Study Warns of Risk From Cardiac Surgery Drug  -  Dec 2, 2008
They recommended tranexamic acid or aminocaproic acid as alternatives to prevent blood loss during surgery. "Lysine analogues are almost as effective as Washington Post,

Another Trasylol Study Finds Cheaper Drugs Less Risky  -  Dec 4, 2008
...“Either tranexamic acid or epsilon aminocaproic acid should be recommended to prevent bleeding after cardiac surgery,� the team wrote. Newsinferno.com,

Common heart surgery drug may be more dangerous than cheaper ...  -  Dec 2, 2008
..."Either tranexamic acid or epsilon aminocaproic acid should be recommended to prevent bleeding after cardiac surgery," the team wrote. CBC.ca,

Bayer’s Trasylol Killed Too Many People; Lawsuits Arrive  -  Dec 3, 2008
They recommended tranexamic acid or aminocaproic acid as alternatives to prevent blood loss during surgery. Sneathia James claims her husband, Sam Lee Erby, BNET,

Trasylol: Blood-Clotting Drug Tied to Kidney Damage, Heart Attack ...  -  Dec 9, 2008
The generic drugs aminocaproic acid and tranexamic acid have been to shown to be effective at controlling bleeding during bypass and cardiac surgeries. Attorney at Law

Trasylol Class Action Lawsuit Filed in Canada After Another Study ...  -  Dec 4, 2008
...were 53% more likely to die than those treated with tranexamic acid (Cyklokapron) and aminocaproic acid (Amicar), which are other anti-bleeding drugs. AboutLawsuits.com

The Use of Antifibrinolytic Agents in Spine Surgery  -  Nov 1, 2008
Conclusions: Aprotinin, tranexamic acid, and epsilon-aminocaproic acid are effective for reducing blood loss and transfusions in patients managed with spine Journal of Bone and Joint Surgery (subscription)

Information About Trasylol (Aprotinin) Being Linked to Tens of ...  -  Oct 2, 2008
There was no increased heart attack risk evident in the Trasylol generic alternatives Aminocaproic acid or Tranexamic acid. Aminocaproic acid and Tranexamic PR Web (press release),

Bayer Withdraws Heart Surgery Drug from US Market Following New ...  -  Oct 9, 2008
...death and other serious complications in 2331 heart surgery patients given either Trasylol, Cyklokapron (tranexamic acid) or Amicar (aminocaproic acid). Natural News.com,

Aprotinin; An economy of truth?  -  Oct 2, 2008
5 In the article from Shaw and colleagues 6 of the Duke University Medical Center, the populations of patients receiving aprotinin or -aminocaproic acid The Journal of Thoracic and Cardiovascular Surgery

A not-so-routine thrombocytopenia  -  Jul 25, 2008
I hadn’t used Amicar (aminocaproic acid) in years, but it had worked great in a patient of mine who had bled severely after a prostate biopsy. HemOncToday,

Trasylol: Pivotal Study Could Have Happened Sooner  -  Jun 7, 2008
A dose of aminocaproic acid, widely felt as equally effective in mitigating bleeding during cardiac surgery but without the risks associated with Trasylol, Lawyers and Settlements

Anti-bleeding drug raises death risk — study  -  May 15, 2008
For every 100 patients getting tranexamic acid or aminocaproic acid, four died, according to the study, published electronically on Wednesday by the New TheChronicleHerald.ca,

A Comparison of Aprotinin and Lysine Analogues in High-Risk ...  -  May 28, 2008
We sought to determine whether aprotinin was superior to either tranexamic acid or aminocaproic acid in decreasing massive postoperative bleeding and other New England Journal of Medicine (subscription),

BART Closes the Book on Aprotinin  -  May 20, 2008
Compare the effect of aprotinin with tranexamic acid vs aminocaproic acid for preventing massive bleeding after high-risk cardiac surgery. Medscape (subscription)

Drug aprotinin boosts risk of death: study  -  May 14, 2008
..."Overall, our study supports the use of tranexamic acid or aminocaproic acid over aprotinin during high-risk heart surgery," stressed Dr. Paul Hebert, AFP

Breastfeeding May Prevent Arthritis, Antifibrinolytic Agents ...  -  May 14, 2008
...about 6% of patients who received aprotinin died within 30 days of surgery compared to 4% of patients who received tranexamic acid or aminocaproic acid. Insider Medicine,

It's Game Over for Trasylol, but Bayer Refuses to Fold  -  May 25, 2008
...patients using aprotinin (Trasylol) were more likely to die than patients administered alternatives--specifically, tranexamic acid or aminocaproic acid. Lawyers and Settlements

Aprotinin (Trasylol) Use in CABG Again Shows Extra Mortality Risk  -  Feb 20, 2008
Patients treated with aprotinin had an almost a two-fold greater mortality compared with patients given aminocaproic acid during heart surgery, MedPage Today,

Suspended heart surgery drug linked to higher death risk, averse ...  -  Feb 20, 2008
...in high risk cardiac patients designed to compare the more expensive aprotinin to two cheaper drugs in the class, aminocaproic acid or tranexamic acid. The Canadian Press

Aprotinin during Coronary-Artery Bypass Grafting and Risk of Death  -  Feb 20, 2008
Postoperative revascularization and dialysis were more frequent among recipients of aprotinin than among recipients of aminocaproic acid. New England Journal of Medicine (subscription),

Bayer hurt by damaging Trasylol data, sued over Kogenate  -  Feb 21, 2008
33517 patients received Trasylol and 44682 were given aminocaproic acid. Overall, 1512 aprotinin patients (4.5%) and 1101 aminocaproic acid patients (2.5%) Pharma Times (subscription),

The Effect of Aprotinin on Outcome after Coronary-Artery Bypass ...  -  Feb 20, 2008
As compared with the use of aminocaproic acid or no antifibrinolytic agent, aprotinin use was also associated with a larger risk-adjusted increase in the New England Journal of Medicine (subscription),

More Evidence of Danger From Heart Surgery Drug  -  Feb 20, 2008
The mortality rate for those taking Trasylol was also 27 percent higher than those given aminocaproic acid, a different medication used to limit bleeding. Washington Post,

Aprotinin under fire: Two new observational studies point to ...  -  Feb 20, 2008
They report that 4.5% of more than 33 500 aprotinin recipients died, vs 2.5% of 44 682 aminocaproic-acid recipients. "The most important finding in our TheHeart.Org,

Cardiac Surgery Drug Increases Death Rate, Study Confirms  -  Feb 23, 2008
Patients who received either aminocaproic acid or no therapy did not have high rates of death or poor kidney function seen in the aprotinin group. Science Daily (press release)

Bayer Responds to Trasylol Studies  -  Feb 22, 2008
Bayer believes that the database selected was unsuitable for comparing the safety of Trasylol and aminocaproic acid (commonly used to reduce bleeding- InjuryBoard.com,

More Evidence Condemns Trasylol and FDA  -  Feb 21, 2008
And the death rate was higher by 27 percent among those given Trasylol over a competing and standard medication used to limit bleeding, aminocaproic acid. InjuryBoard.com,

Guidelines Issued for Diagnosis and Management of von Willebrand's ...  -  Mar 5, 2008
The antifibrinolytic drugs aminocaproic acid and tranexamic acid can also be used to treat mild mucocutaneous bleeding in VWD. Concentrates of VWF can be Medscape (subscription)

Drug used in cardiac surgery increases death rate  -  Feb 20, 2008
Of the 10275 patients studied in the new study, 1343 (13.2 percent) received Aprotinin, 6776 (66.8 percent) received Aminocaproic acid - another drug used KalingaTimes,

Aprotinin Safe in On-Pump but Not Off-Pump CABG  -  Feb 13, 2008
He adds that in the meantime, many centers are now using alternative products such as epsilon-aminocaproic acid or tranexamic acid, "but no one has really Medscape (subscription)

Bayer Drug Alleged to Have Led to 22000 Deaths  -  Feb 19, 2008
Trasylol was 20.8 percent, compared to 15.8 percent for those given another drug, aminocaproic acid, and 14.7 percent for those given tranexamic acid. Best Syndication,

Bayer's Trasylol Boosts Death, Kidney Risks After Heart Surgery  -  Feb 20, 2008
...analyzed the data and accounted for differences between the patients getting Trasylol and those on the alternate, generic drug aminocaproic acid. Bloomberg

LeftBlog: An ppen letter to Congressman Dr. Charles Boustany Jr.  -  Feb 19, 2008
Both of these medications Aminocaproic acid and Tranexamic acid respectively, act without the renal damage or the $1000 price tag of Trasylol. The Daily Advertiser,

FDA Fails - The Story of Joseph Randone  -  Feb 17, 2008
In contrast, the less expensive generic medications aminocaproic acid and tranexamic acid are safe alternatives." In the case of Trasylol, Bayer hired a InjuryBoard.com,





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy